Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

María Noé Garcia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-2167-1298; OpenAlex author ID A5004147261. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 4 papers

Papers 10

  1. Type I interferons modulate autophagy to shape gemcitabine response in pancreatic cancer cells. Co-author DOI 10.1002/2211-5463.70342↗
  2. Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities. Co-author DOI 10.1016/j.isci.2026.115164↗
  3. Pathway-driven therapeutic stratification in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2026.102920↗
  4. Small CD63 + CD81+ extracellular vesicles induce autophagy via the FOXO3a pathway in pancreatic cancer cells during starvation. Last author DOI 10.1038/s41598-026-52731-0↗
  5. [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. Co-author PMID 37582144↗
  6. Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer. Co-author DOI 10.3390/molecules27113492↗
  7. Autophagy-Mediated Exosomes as Immunomodulators of Natural Killer Cells in Pancreatic Cancer Microenvironment. First author DOI 10.3389/fonc.2020.622956↗
  8. IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation. Co-author DOI 10.1172/jci76037↗
  9. NUPR1 works against the metabolic stress-induced autophagy-associated cell death in pancreatic cancer cells. Co-author DOI 10.4161/auto.22258↗
  10. Autophagy in pancreatic cancer. First author DOI 10.1155/2012/760498↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel Grasso · 10 shared papers, 2012–2026 · strength 1.62
  2. Daniela Laura Papademetrio · 7 shared papers, 2020–2026 · strength 1.49
  3. Elida E. Alvarez · 3 shared papers, 2020–2026 · strength 0.74
  4. Juan Iovanna · 6 shared papers, 2012–2026 · strength 0.69
  5. Oscar Mazza · 3 shared papers, 2023–2026 · strength 0.57
  6. María Eugenia Pasqualini · 3 shared papers, 2023–2026 · strength 0.57
  7. Agustín Yaneff · 3 shared papers, 2023–2026 · strength 0.57
  8. Nicolas Alejandro Fraunhoffer · 3 shared papers, 2023–2026 · strength 0.57
  9. Eduardo Chuluyán · 3 shared papers, 2023–2026 · strength 0.57
  10. Nelson Dusetti · 3 shared papers, 2023–2026 · strength 0.57
  11. Jonathan Garnier · 2 shared papers, 2026 · strength 0.42
  12. Brice Chanez · 2 shared papers, 2026 · strength 0.42
  13. Ana Sahores · 2 shared papers, 2023–2026 · strength 0.35
  14. Lucy Elena Bonilla · 1 shared paper, 2026 · strength 0.28
  15. Analía Meilerman Abuelafia · 1 shared paper, 2026 · strength 0.21
  16. Pascal R. Hammel · 1 shared paper, 2026 · strength 0.21
  17. Nadia Talin Mirakian · 1 shared paper, 2022 · strength 0.19
  18. Laura Cecilia Laurella · 1 shared paper, 2022 · strength 0.19
  19. Betina González · 1 shared paper, 2023 · strength 0.14
  20. Carlos Alberto Davio · 1 shared paper, 2023 · strength 0.14
  21. Patricia Santofimia-Castaño · 1 shared paper, 2023 · strength 0.14
  22. Tewfik Hamidi · 2 shared papers, 2013–2014 · strength 0.07
  23. Raul A. Urrutia · 2 shared papers, 2013–2014 · strength 0.07
  24. Gwen Alyce Lomberk · 2 shared papers, 2013–2014 · strength 0.07
  25. Céline Loncle · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.